FBXW10 is negatively regulated in transcription and expression level by protein O-GlcNAcylation

Biochemical and Biophysical Research Communications

Volumn 438, Issue 2, 2013, Pages 427-432

  Feng, Zhou ^a,b   Hui, Yan ^a   Ling, Li ^a   Xiaoyan, Liu ^a   Yuqiu, Wang ^a   Peng, Wang ^a   Lianwen, Zhang ^a  

^a NANKAI UNIVERSITY   (China)

^b TIANJIN UNIVERSITY   (China)

Author keywords

Cross talk; F box protein; FBXO4; FBXW10; O GlcNAcylation; Ubiquitination

Indexed keywords

F BOX PROTEIN; FBXO3 PROTEIN; FBXO31 PROTEIN; FBXW10 PROTEIN; FBXW9 PROTEIN; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN MODIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UBIQUITINATION; WESTERN BLOTTING;

CROSS-TALK; F-BOX PROTEIN; FBXO4; FBXW10; O-GLCNACYLATION; UBIQUITINATION;

F-BOX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; PLASMIDS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; TRANSCRIPTION, GENETIC; UBIQUITIN; UBIQUITINATION;

EID: 84882731508     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.07.091     Document Type: Article

References (26)

1. Bhat K.P., Greer S.F. Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation. Biochim. Biophys. Acta 1809, 2011:150-155.
2. Nakayama K. Growth and progression of melanoma and non-melanoma skin cancers regulated by ubiquitination. Pigment Cell Melanoma Res. 2010, 23:338-351.
3. Welchman R.L., Gordon C., Mayer R.J. Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat. Rev. Mol. Cell Bio. 2005, 6:599-609.
4. Guinez C., Mir A.M., Dehennaut V., Cacan R., Harduin-Lepers A., Michalski J.C., Lefebvre T. Protein ubiquitination is modulated by O-GlcNAc glycosylation. FASEB J. 2008, 22:2901-2911.
5. Zhang F.X., Su K.H., Yang X.Y., Bowe D.B., Paterson A.J., Kudlow J.E. O-GIcNAc modification is an endogenous inhibitor of the proteasome. Cell 2003, 115:715-725.
6. Yang W.H., Kim J.E., Nam H.W., Ju J.W., Kim H.S., Kim Y.S., Cho J.W. Modification of p53 with O-linked N-acetylglucosamine regulates p53 activity and stability. Nat. Cell Biol. 2006, 8:1074-1083.
7. Teo C.F., Ingale S., Wolfert M.A., Elsayed G.A., Not L.G., Chatham J.C., Wells L., Boons G.J. Glycopeptide-specific monoclonal antibodies suggest new roles for O-GlcNAc. Nat. Chem. Biol. 2010, 6:338-343.
8. Fujiki R., Hashiba W., Sekine H., Yokoyama A., Chikanishi T., Ito S., Imai Y., Kim J., He H.H., Igarashi K., Kanno J., Ohtake F., Kitagawa H., Roeder R.G., Brown M., Kato S. GlcNAcylation of histone H2B facilitates its monoubiquitination. Nature 2011, 480:557-560.
9. Zaro B.W., Yang Y.Y., Hang H.C., Pratt M.R. Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1. Proc. Natl. Acad. Sci. USA 2011, 108:8146-8151.
10. Wang Z., Udeshi N.D., Slawson C., Compton P.D., Sakabe K., Cheung W.D., Shabanowitz J., Hunt D.F., Hart G.W. Extensive cross talk between O-GlcNAcylation and phosphorylation regulates cytokinesis. Sci. Signal. 2010, 3. Ra2.
11. Klement E., Lipinszki Z., Kupihar Z., Udvardy A., Medzihradszky K.F. Enrichment of O-GlcNAc modified proteins by the periodate oxidation-hydrazide resin capture approach. J. Proteome Res. 2010, 9:2200-2206.
12. Cole R.N., Hart G.W. Cytosolic O-glycosylation is abundant in nerve terminals. J. Neurochem. 2001, 79:1080-1089.
13. Hardiville S., Hoedt E., Mariller C., Benaissa M., Pierce A. O-GlcNAcylation/phosphorylation cycling at ser(10) controls both transcriptional activity and stability of delta-lactoferrin. J. Biol. Chem. 2010, 285:19205-19218.
14. Mariller C., Hardiville S., Hoedt E., Benaissa M., Mazurier J., Pierce A. Proteomic approach to the identification of novel delta-lactoferrin target genes: characterization of DcpS, an mRNA scavenger decapping enzyme. Biochimie 2009, 91:109-122.
15. Xing D., Gong K., Feng W., Nozell S.E., Chen Y.F., Chatham J.C., Oparil S. O-GlcNAc modification of NFkappaB p65 inhibits TNF-alpha-induced inflammatory mediator expression in rat aortic smooth muscle cells. PLoS One 2011, 6:e24021.
16. Kneass Z.T., Marchase R.B. Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils. J. Biol. Chem. 2005, 280:14579-14585.
17. Cieniewski-Bernard C., Montel V., Berthoin S., Bastide B. Increasing O-GlcNAcylation level on organ culture of soleus modulates the calcium activation parameters of muscle fibers. PLoS One 2012, 7:e48218.
18. Hilgers R.H.P., Xing D.Q., Gong K.Z., Chen Y.F., Chatham J.C., Oparil S. Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction. Am. J. Physiol. Heart Circ. Physiol. 2012, 303:H513-H522.
19. Xing D.Q., Gong K.Z., Feng W.G., Nozell S.E., Chen Y.F., Chatham J.C., Oparil S. O-GlcNAc Modification of NF kappa B p65 Inhibits TNF-alpha-induced inflammatory mediator expression in rat aortic smooth muscle cells. PLoS One 2011, 6.
20. Ngoh G.A., Watson L.J., Facundo H.T., Dillmann W., Jones S.P. Non-canonical glycosyltransferase modulates post-hypoxic cardiac myocyte death and mitochondrial permeability transition. J. Mol. Cell. Cardiol. 2008, 45:313-325.
21. Hamiel C.R., Pinto S., Hau A., Wischmeyer P.E. Glutamine enhances heat shock protein 70 expression via increased hexosamine biosynthetic pathway activity. Am. J. Physiol. Cell Physiol. 2009, 297:C1509-1519.
22. Robinson K.A., Ball L.E., Buse M.G. Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 2007, 292:E884-890.
23. Hart G.W., Slawson C., Ramirez-Correa G., Lagerlof O. Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 2011, 80:825-858.
24. Skaar J.R., D'Angiolella V., Pagan J.K., Pagano M. SnapShot: F box proteins II. Cell 2009, 137:1358. 1358 e1351.
25. Glenn K.A., Nelson R.F., Wen H.M., Mallinger A.J., Paulson H.L. Diversity in tissue expression, substrate binding, and SCF complex formation for a lectin family of ubiquitin ligases. J. Biol. Chem. 2008, 283:12717-12729.
26. Chaturvedi P., Parnaik V.K. Lamin A rod domain mutants target heterochromatin protein 1alpha and beta for proteasomal degradation by activation of F-box protein, FBXW10. PLoS One 2010, 5:e10620.